Translate this page into:
Rosai-Dorfman disease of the breast: A case report of a rare extranodal presentation with imaging correlation
*Corresponding author: Aditya Amar Shitole, Department of Radiology, Smt. Kashibai Navale Medical College and General Hospital, Ambegaon, Pune, India. adityashitole610@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Shitole AA, Singh H. Rosai-Dorfman disease of the breast: A case report of a rare extranodal presentation with imaging correlation. Indian J Breast Imaging. 2025;3:102–104. doi: 10.25259/IJBI_4_2025
Abstract
Rosai-Dorfman disease (RDD) is a rare, benign, idiopathic histiocytic proliferative disorder, primarily affecting the lymph nodes but also involving extranodal sites. RDD confined to the breast is extremely rare, with fewer than 100 cases reported in the literature, and it often mimics malignancy on imaging. We report a case of a 45-year-old male presenting with bilateral breast lumps, more prominent on the right. Mammography and ultrasound demonstrated features suspicious for malignancy, including irregular margins, internal vascularity, and mild surrounding edema. Histopathological analysis revealed lymphoplasmacytic infiltration, large histiocytes exhibiting emperipolesis, and strong positivity for S-100 and CD68. Early recognition of RDD prevented unnecessary surgical intervention. This report highlights key imaging and pathological features that differentiate RDD from malignancy.
Keywords
Breast imaging
Gynecomastia
Male breast mass
Mammography
Rosai-Dorfman disease
INTRODUCTION
Rosai-Dorfman disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy, is a rare, benign proliferative disorder of histiocytes. It predominantly affects young adults and children, with primary involvement of cervical lymph nodes. However, extranodal involvement occurs in up to 43% of cases, commonly affecting the skin, orbit, central nervous system, and, rarely, the breast. Breast involvement is exceptionally rare and can occur as an isolated manifestation or alongside systemic disease. The diagnosis of RDD confined to the breast is challenging due to its imaging resemblance to malignancy. Core biopsy with immunohistochemical staining is crucial in differentiating RDD from carcinoma, avoiding unnecessary surgical excision.[1]
CASE REPORT
A 45-year-old male presented with a 3-month history of bilateral breast lumps, more prominent on the right. He denied fever, weight loss, or night sweats. Clinical examination revealed firm, mobile breast lesions bilaterally without associated axillary lymphadenopathy. There was no known personal or family history of autoimmune disorders, malignancy, or systemic histiocytic disease.
Imaging Findings
Breast Ultrasound: A hypoechoic, wider-than-tall lesion with irregular margins, mild posterior acoustic enhancement, internal vascularity, and surrounding edema. Associated gynecomastia was noted in bilateral breasts. Color Doppler confirmed internal vascularity [Figure 1].
Mammography: Circumscribed, non-calcified mass with mild architectural distortion but no nipple retraction or microcalcifications. The lesion was classified as BI-RADS 4 due to suspicious morphology [Figure 2].

- A 45-year-old male with bilateral breast lumps (more prominent on the right). (a) Transverse B mode ultrasound image of the right breast demonstrates an oval hypoechoic mass, parallel to the chest wall (yellow arrow) in the subareolar location with lobulated margins. The surrounding breast parenchyma exhibits features of gynecomastia. (b) Transverse B mode ultrasound image of the right breast demonstrates a hypoechoic mass (white arrow) in the subareolar location showing internal vascularity on color Doppler images.

- Mediolateral oblique view of the right breast on mammography reveals a retroareolar mass (white arrow) with no associated calcifications, closely mimicking malignancy.
Histopathology
Core biopsy of the right breast lesion revealed dense inflammatory infiltrate with a predominance of lymphoplasmacytic cells and histiocytes. The histiocytes demonstrated emperipolesis, a characteristic feature of RDD, where histiocytes engulf other cells (such as lymphocytes or plasma cells) but retain them intact within the cytoplasm. Immunohistochemistry confirmed strong and diffuse S-100 positivity, with a subset of cells staining for CD68, supporting the diagnosis of RDD [Figure 3]. No evidence of malignancy was noted. The Ki-67 proliferation index was low (<5%), supporting a benign etiology.

- Histopathology of the right breast lesion (Hematoxylin and Eosin stain, 200x magnification). The image demonstrates emperipolesis, a hallmark feature of Rosai-Dorfman disease, where intact lymphocytes are seen within the cytoplasm of large histiocytes. A dense inflammatory infiltrate composed predominantly of histiocytes and lymphoplasmacytic cells is also observed, along with preserved tissue architecture.
DISCUSSION
RDD of the breast is exceedingly rare and often presents as a palpable mass concerning for malignancy. To date, fewer than 100 cases have been reported worldwide, with a significant female predominance (approximately 10:1) and a median age of 55 years (range: 15–84). In reported cases, mammography frequently shows focal asymmetry, while ultrasound reveals solid, irregular masses with internal vascularity and surrounding edema—features that strongly mimic malignancies.[2]
Typical Imaging Findings in Breast RDD Include
On ultrasound: A hypoechoic, irregular, or lobulated mass with internal vascularity on Doppler, occasionally with mild posterior enhancement.
On mammography: Focal asymmetry or irregular, non-calcified masses without specific distinguishing features from carcinoma.
In our case, the imaging findings were largely consistent with prior reports, including a hypoechoic, wider-than-tall mass with irregular margins, internal vascularity, and mild surrounding edema on ultrasound, and a non-calcified mass with mild architectural distortion on mammography. However, our case presented with bilateral breast involvement, which is rarely reported in the literature, as most documented cases are unilateral. Additionally, the presence of associated gynecomastia in both breasts may represent a reactive or coincidental finding, but it adds an uncommon radiologic context not widely described in previous reports.[3]
Given these radiological similarities to breast carcinoma, histopathology remains the gold standard for definitive diagnosis. The presence of emperipolesis and strong S-100 positivity differentiates RDD from other benign and malignant breast lesions. The differential diagnosis includes carcinoma, lymphoma, granulomatous mastitis, and idiopathic histiocytic disorders. Unlike malignancies, RDD lesions lack necrosis and demonstrate preserved architecture on imaging.
Laterality is often unilateral, though bilateral involvement (as in our case) is rare. Axillary lymphadenopathy is reported in only ~5% of mammary RDD cases.[4]
Complications in RDD are generally uncommon but may include progressive local disease, recurrent mass formation, or compressive symptoms depending on lesion size and location. Systemic symptoms such as fever, weight loss, and lymphadenopathy may occur if other extranodal sites are involved. In rare cases, aggressive or disseminated forms of RDD can occur, particularly in association with immune dysfunction or systemic inflammatory diseases. However, no complications were observed in our patient, and clinical follow-up showed stability.
While surgical excision was historically performed for diagnosis, core biopsy is now preferred for early identification of RDD, preventing unnecessary surgical interventions. The preferred management is conservative observation, as spontaneous regression is common. However, in cases with progressive symptoms or systemic involvement, corticosteroids, immunosuppressants, or chemotherapy may be considered.[5]
CONCLUSION
Rosai-Dorfman disease (RDD) can present as well-defined, ill-defined, or irregular breast masses that mimic malignancy. Our case highlights the importance of including RDD in the differential diagnosis of breast masses. Imaging features such as internal vascularity, irregular margins, and mild edema necessitate histopathological confirmation via core biopsy. Given the rarity of RDD and absence of standardized follow-up protocols, management should be individualized. Early diagnosis facilitates conservative treatment and avoids unnecessary interventions.
Acknowledgements
Dr. Prashant Naik, Professor and HOD, Department of Radiology, Smt. Kashibai Navale Medical College and Hospital, Ambegaon, Pune. DR. Siddhi Khandeparkar, Professor and HOD, Department of Pathology, for providing the histopathological image and legends used in this case report. Their support and contribution are gratefully appreciated.
Ethical approval
Institutional Review Board approval is not required.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
REFERENCES
- Imaging features of extranodal Rosai-Dorfman disease. J Radiol Case Rep. 2021;62:222-7.
- [Google Scholar]
- Avoiding misdiagnosis in rare breast pathologies. Breast Pathol Rev. 2018;32:89-96.
- [Google Scholar]
- Surgical outcomes in rare breast tumors: A multicenter study. Surg Today. 2021;51:1452-8.
- [Google Scholar]
